The Cancer Institute unites physicians, nurses and researchers from the University of Mississippi Medical Center and the University of Mississippi in the quest to stop cancer through:
Adult and pediatric physicians see more than 2,000 new patients annually and follow more than 5,800 survivors. Cancer teams see many people with rare or complex care needs.
Monday, October 1, 2018
UMMC now holds five patents associated with elastin-like polypeptides, a versatile family of synthetic molecules that could change how diseases are treated. The efforts of multiple UMMC faculty members have resulted in a portfolio of ELP-related intellectual property that is one of the largest in the United States. Read More
Friday, September 21, 2018
UMMC Cancer Institute director received praise for his years of work with the American Cancer Society to further patient therapies and support the organization's research and patient care efforts. Read More
Medical Center among ELP research, patent leaders
Published on Monday, October 1, 2018
Morgan joins lung, GI cancer teams
Published on Wednesday, September 26, 2018
American Cancer Society honors Ruckdeschel with St. George Award
Published on Friday, September 21, 2018
Procedure eases complications related to fluid around lungs
Published on Thursday, August 23, 2018
Dr. Laura Newman treats young hematology, oncology patients at alma mater
Published on Thursday, August 16, 2018
Mohs surgery leaves few signs of melanoma
Published on Monday, August 6, 2018
Collier to head Children’s Cancer Center
Published on Thursday, July 12, 2018
Interdisciplinary teams meet regularly to review each new patient’s case and recommend the best treatment for each individual. Doctors here see many unusual and complex cases.
The Cancer Institute offers the state’s only residency and fellowship programs for professionals seeking a career in cancer care.
Researchers and physicians at UMMC and at the University of Mississippi are working together to seek new and better ways to prevent, detect and treat cancer.